Japan’s MHLW To Set Up Rapid Evaluation System For Advanced Medical Technology And Pharmaceuticals
This article was originally published in PharmAsia News
Japan’s MHLW plans to introduce a new system, tentatively named the “rapid assessment system for advanced medical care,” to speed up the evaluation of medical technology and pharmaceuticals products not covered by health insurance and used in non-insured treatments.
You may also be interested in...
GNC hires Josh Burris as chief US officer; Clasado BioSciences adds Bellchambers as commercial director; and Barentz plans expansion with Cinven investment.
The House passage of a Democratic bill authorizing the federal government to negotiate drug prices in Medicare has sharpened the debate over how prices feed innovation, but the underlying policy stands little chance of being enacted without a Democratic wave in the next election. Pink Sheet's table highlights the key provisions of HR 3 and other pending pricing legislation.